Subsequently, two other groups [13,84] corroborated these findings, showing that RHOA-G17V is a loss-of-function mutation able to drive AITL with high proliferative and invasive capacity. This evidence concerns the gene RHOA and angioimmunoblastic T-cell lymphoma.